Published in Ann Dermatol Venereol on January 01, 1993
Nattrassia mangiferae: An uncommon agent of onychomycosis. Med J Armed Forces India (2013) 0.75
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med (1992) 2.54
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis (1988) 2.19
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn (1995) 1.59
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
[Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma]. Ann Dermatol Venereol (2013) 1.44
Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42
Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study. Br J Dermatol (2014) 1.39
Adult onset Still's disease and pregnancy. J Rheumatol (1993) 1.39
[Contact vasculitis caused by topical agents with non-steroidal anti-inflammatory agents or analgesics]. Ann Dermatol Venereol (1997) 1.38
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol (2001) 1.28
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23
Comparison of minus power anterior chamber intraocular lenses and myopic epikeratoplasty in phakic eyes. Refract Corneal Surg (1991) 1.23
Association of major aphthous ulcers and nicorandil. Lancet (1998) 1.22
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum (2000) 1.19
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13
Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods. Control Clin Trials (2001) 1.12
Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis (1999) 1.12
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am J Surg Pathol (1999) 1.10
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus. J Antimicrob Chemother (1987) 1.09
Severe Liver Disease in Children With α-1 Antitrypsin Deficiency in France (DEFI-ALPHA Cohort). J Pediatr Gastroenterol Nutr (2015) 1.08
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06
Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol (2011) 1.04
Incidence and mortality of Alzheimer's disease or dementia using an illness-death model. Stat Med (2004) 1.02
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.02
Re: "Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study". Am J Epidemiol (1997) 1.01
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev (2013) 1.00
Neoteny and progenesis as two heterochronic processes involved in paedomorphosis in Triturus alpestris (Amphibia: Caudata). Proc Biol Sci (2000) 1.00
Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients. J Eur Acad Dermatol Venereol (2009) 1.00
Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis. Am Rev Respir Dis (1990) 1.00
Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.00
[Histological and clinical forms of the eosinophilic cellulitis]. Ann Dermatol Venereol (2001) 1.00
Escape behaviour and ultimate causes of specific induced defences in an anuran tadpole. J Evol Biol (2005) 0.99
Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol (2013) 0.99
[Septic arthritis caused by Campylobacter fetus]. Rev Rhum Mal Osteoartic (1986) 0.97
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response. Arteriosclerosis (1989) 0.96
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol (2012) 0.94
Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol (2003) 0.94
Tadpoles' responses to risk of fish introduction. Oecologia (2002) 0.94
Expression of pemphigus-autoantigen desmoglein 1 in human thymus. Tissue Antigens (2008) 0.92
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol (1998) 0.92
[Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies]. Ann Pathol (2000) 0.91
Skin swabbing as a new efficient DNA sampling technique in amphibians, and 14 new microsatellite markers in the alpine newt (Ichthyosaura alpestris). Mol Ecol Resour (2012) 0.91
Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol (2001) 0.90
[Atypical genital necrobiosis lipoidica]. Ann Dermatol Venereol (1984) 0.90
[Cutaneous aseptic abscesses, manifestations of neutrophilic diseases]. Ann Dermatol Venereol (2001) 0.90
[Localized bullous pemphigoid following radiotherapy]. Ann Dermatol Venereol (2000) 0.90
Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol (2000) 0.89
Renal chromophobe cell carcinoma and paraneoplastic linear IgA bullous dermatosis. J Urol (2003) 0.89
Cutaneous lymphomas other than mycosis fungoides. Semin Dermatol (1994) 0.89
[Generalized pseudoxanthoma elasticum combined with vitamin K dependent clotting factors deficiency]. Ann Dermatol Venereol (1996) 0.89
Heterozygosity-fitness correlations among wild populations of European tree frog (Hyla arborea) detect fixation load. Mol Ecol (2011) 0.89
Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol (1994) 0.88
Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J Eur Acad Dermatol Venereol (2011) 0.88
Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med (2004) 0.88
Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol (2011) 0.87
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer (2001) 0.87
[Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis]. Ann Dermatol Venereol (2010) 0.86
Cutaneous abscess: a rare complication of Streptobacillus moniliformis infection. Br J Dermatol (1993) 0.86
Leflunomide-induced subacute cutaneous lupus erythematosus. Rheumatology (Oxford) (2005) 0.86
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol (1999) 0.86
Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol (1997) 0.85
Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol (1994) 0.85
[Syringomatous carcinoma a propos of three cases with a review of the literature]. Ann Pathol (1995) 0.85
Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch Dermatol (1999) 0.85
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas. Blood (1999) 0.84
A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev Rhum Engl Ed (1996) 0.84
[Miescher's cheilitis and lymphocytic clonal expansion: 2 cases]. Ann Dermatol Venereol (2004) 0.84
Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis. Br J Dermatol (1991) 0.84
Risk factors for abscess formation in patients with superficial cellulitis (erysipelas) of the leg. Br J Dermatol (2013) 0.84
Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2012) 0.84
Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis. Arch Dermatol (2000) 0.84
[Melkersson-Rosenthal syndrome treated by thalidomide. 2 cases]. Ann Dermatol Venereol (1995) 0.84
Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. J Eur Acad Dermatol Venereol (2013) 0.83
Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab (2005) 0.83
Consequences of genetic erosion on fitness and phenotypic plasticity in European tree frog populations (Hyla arborea). J Evol Biol (2010) 0.83
Nested frailty models using maximum penalized likelihood estimation. Stat Med (2006) 0.83
Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol (2014) 0.83
[Recurrent (Weber-Christian) panniculitis and liquefying (Rothman's) panniculitis]. Bull Soc Fr Dermatol Syphiligr (1969) 0.83